Arrhythmia News and Research

RSS
An arrhythmia is a problem with the speed or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. A heartbeat that is too fast is called tachycardia. A heartbeat that is too slow is called bradycardia. Most arrhythmias are harmless, but some can be serious or even life threatening. When the heart rate is too slow, too fast, or irregular, the heart may not be able to pump enough blood to the body. Lack of blood flow can damage the brain, heart, and other organs.
New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation

New report calls for greater awareness and emphasis on scale and impact of atrial fibrillation

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Using genome editing to prevent sudden cardiac death

Using genome editing to prevent sudden cardiac death

AR may help cardiologists plan and perform complex medical interventions

AR may help cardiologists plan and perform complex medical interventions

Study compares programming strategies used in implanted cardiac defibrillators

Study compares programming strategies used in implanted cardiac defibrillators

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

More accurate and less stressful way to measure a baby's heartbeat

More accurate and less stressful way to measure a baby's heartbeat

Diagnosing Atrial Fibrillation in 30 Seconds

Diagnosing Atrial Fibrillation in 30 Seconds

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

EU conducts research into mechanisms and effects of atrial fibrillation

EU conducts research into mechanisms and effects of atrial fibrillation

Family history in blacks, Latinos associated with higher risk of AFib

Family history in blacks, Latinos associated with higher risk of AFib

Johns Hopkins scientists successfully perform 3D personalized virtual simulations of the heart

Johns Hopkins scientists successfully perform 3D personalized virtual simulations of the heart

Awareness of arrhythmia symptoms to prevent stroke and heart failure

Awareness of arrhythmia symptoms to prevent stroke and heart failure

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Drug used for chest pain does not decrease chance of first occurrence of ventricular arrhythmias

Drug used for chest pain does not decrease chance of first occurrence of ventricular arrhythmias

Left atrial fibrosis may indicate high risk of arrhythmias in trained endurance athletes

Left atrial fibrosis may indicate high risk of arrhythmias in trained endurance athletes

VTCRI study may disrupt conventional understanding about how electrical activity travels in the heart

VTCRI study may disrupt conventional understanding about how electrical activity travels in the heart

Philips introduces new cardiovascular ultrasound system with anatomical intelligence

Philips introduces new cardiovascular ultrasound system with anatomical intelligence

Desert bush spider toxin helps researchers to better understand human and insect biology

Desert bush spider toxin helps researchers to better understand human and insect biology